Progress and controversies in neoadjuvant therapy

被引：0

作者：

Edwin M. Posadas

Robert A. Figlin

机构：

[1] Urologic Oncology Program,

[2] Samuel Oschin Comprehensive Cancer Institute,undefined

[3] Cedars–Sinai Medical Center,undefined

来源：

Nature Reviews Urology | 2014年 / 11卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Use of clinically active agents, such as kinase inhibitors, before nephrectomy is safe and feasible and can decrease the size of primary tumours, enabling optimization of the surgical approach. However, the overall clinical benefit of the neoadjuvant use of toxic drugs, such as axitinib, has not yet been demonstrated.

引用

页码：254 / 256

页数：2

共 50 条

[41] The Casimir effect: recent controversies and progress
Milton, KA
JOURNAL OF PHYSICS A-MATHEMATICAL AND GENERAL, 2004, 37 (38): : R209 - R277
[42] Progress and controversies in developing cancer vaccines
Craig L Slingluff
Daniel E Speiser
Journal of Translational Medicine, 3
[43] Controversies in antidepressant therapy
Pariante, CM
Tansella, M
EPIDEMIOLOGIA E PSICHIATRIA SOCIALE, 2005, 14 (02): : 51 - 54
[44] CONTROVERSIES IN RADIOIODINE THERAPY
GROSS, MD
JOURNAL OF NUCLEAR MEDICINE, 1988, 29 (12) : 2026 - 2027
[45] Controversies in tocolytic therapy
Katz, VL
Farmer, RM
CLINICAL OBSTETRICS AND GYNECOLOGY, 1999, 42 (04): : 802 - 819
[46] Controversies in Testosterone Therapy
Twitchell, David K.
Pastuszak, Alexander W.
Khera, Mohit
SEXUAL MEDICINE REVIEWS, 2021, 9 (01) : 149 - 159
[47] Controversies in Antifungal Therapy
Gin, Alfred
CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2008, 61 : 27 - 27
[48] CONTROVERSIES IN DIGITALIS THERAPY
BEREGOVICH, J
REVISTA MEDICA DE CHILE, 1990, 118 (07) : 805 - 810
[49] Neoadjuvant hormonal radiotherapy for prostate cancer: Status and controversies
Roach, M
Porter, AT
MOLECULAR UROLOGY, 1998, 2 (03) : 111 - 117
[50] Adjuvant and neoadjuvant chemotherapy for bladder cancer: management and controversies
Jorge A Garcia
Robert Dreicer
Nature Clinical Practice Urology, 2005, 2 : 32 - 37

← 1 2 3 4 5 →